Kolexia
Louafi Samy Gastro-entérologie
Louafi Samy
Gastro-entérologie
Centre Hospitalier des Deux Vallées Nord Essonne
Longjumeau, France
78 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Métastase tumorale Adénocarcinome Tumeurs du foie Carcinomes Tumeurs du côlon Tumeurs des voies biliaires Cholangiocarcinome Carcinome épidermoïde

Collaborateurs

Voir plus
Taieb Julien
Taieb Julien
Hôpital Européen Georges Pompidou, Paris, France
Tougeron David
Tougeron David
Hôpital La Miletrie, Poitiers, France
Coriat Romain
Coriat Romain
Hôpital Cochin, Paris, France
Bouche Olivier
Bouche Olivier
Hôpital Robert-Debré Reims, Reims, France

Industries

Voir plus
Amgen
10 collaboration(s)
Dernière en 2023
Servier
4 collaboration(s)
Dernière en 2023
Sanofi
3 collaboration(s)
Dernière en 2021
MSD
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
OSCAR: Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   16 août 2023
Circulating tumour DNA at baseline for individualised prognostication in patients with chemotherapy-naïve metastatic colorectal cancer. An AGEO prospective study.
European journal of cancer (Oxford, England : 1990)   07 juin 2023
AMEBICA: Randomised Phase II/III Study, Assessing the Safety and Efficacy of Modified Folfirinox Versus Gemcis in Locally Advanced, Unresectable and/or Metastatic Bile Duct Tumours
Essai Clinique (CHU Saint-Étienne)   23 février 2022
Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   18 octobre 2021
Metastatic colorectal carcinoma with signet-ring cells: Clinical, histological and molecular description from an Association des Gastro-Entérologues Oncologues (AGEO) French multicenter retrospective cohort.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   09 août 2021
Treatment with encorafenib and cetuximab of a non-anti-epidermal growth factor receptor-naive patient for BRAF V600E-mutated metastatic colon cancer.
European journal of cancer (Oxford, England : 1990)   28 mai 2021
Prognostic factors of colorectal cancer patients with brain metastases.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   16 février 2021
52P Modified FOLFIRINOX versus CISGEM as first-line chemotherapy for advanced biliary tract cancer: Results of AMEBICA PRODIGE 38 randomized phase II trial
Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020   01 septembre 2020
Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma: The Federation Francophone de Cancérologie Digestive-PRODIGE 37 randomised phase II study (FIRGEMAX).
European journal of cancer (Oxford, England : 1990)   02 juillet 2020
Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI)-PRODIGE 62: A multicentre, randomised, non-comparative phase II study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   30 décembre 2019